Formulation Featured Articles

  1. A Viral Testing Facility – Striving For Excellence 5/27/2026

    A GLP-certified viral testing facility ensures biologics safety through comprehensive detection and clearance services, supporting compliance and consistent production of high-quality therapeutics.

  2. Managing Volatility, Complexity, And Risk In Injectable Manufacturing 5/26/2026

    Modern injectables raise sterile fill–finish complexity and risk, making capacity, yield protection, integrated analytics, and supply‑chain resilience essential from development to commercial launch.

  3. Keeping mAb Aggregation Low During The Final UF/DF Step 5/22/2026

    mAb aggregation can arise from molecular properties, process conditions, and equipment‑driven stress. Learn where aggregation risk increases across downstream processing and formulation.

  4. Enhancing Biologics Developability With Predictive In Silico Modelling 5/19/2026

    Predictive in silico modeling accelerates biologics development by identifying stability and formulation risks early, enabling smarter candidate selection, reduced costs, and improved success rates.

  5. In Vivo Manufacturing: When The Body Becomes The Bioreactor 5/15/2026

    Breakthrough therapies are reshaping medicine, but manufacturing complexity is holding them back. Discover how rethinking production and delivery could expand reach and improve patient experience.

  6. Can A Biotech Create A CDMO Market? 5/11/2026

    Can a biotech create a CDMO market? GeoVax, an infectious disease/oncology biotech, may have just done so. David Dodd, CEO, believes we should all concentrate more on whether the outsourcing model can align with evolving technology platforms. Both sponsors and CDMOs may need to change things up.

  7. Chirality In Drug Development: From Racemic Mixtures To Enantiopure Substances 5/6/2026

    Chiral crystallization enables efficient production of enantiopure drug substances, improving pharmacological control and safety while supporting scalable, cost‑effective small molecule development.

  8. Optimising Solubility: Selecting The Right Technology For Early Drug Development 5/6/2026

    Discover how selecting the right solubility‑enhancing technology improves early exposure, supports flexible dosing, and lays a strong foundation for downstream oral drug development.

  9. Why Dilution Gets Tricky: The Role Of Measurement Variability 5/5/2026

    Dilution's effects on downstream processes and final formulation is often understated. A statistical framework can quantify measurement uncertainty's impacts.

  10. How Rheology Ensures Effective Quality Control 5/1/2026

    Rheology connects formulation science to manufacturing reality. By tracking how drugs flow and respond to stress, teams can prevent batch variability and protect dosage performance.